James Appleman

James Appleman

Company: Primmune Therapeutics

Job title: Senior Vice President R&D & Chief Scientific Officer

Seminars:

Speaker Q&A 2:35 pm

Read more

day: Day One

PRTX007, A Novel Orally Administered TLR7 Agonist Prodrug for the Treatment of Cancer 1:45 pm

Unique pharmacology elicited by PRTX007 distinguishes this from other TLR7 agonists This clinical candidate is the result of an extensive medicinal chemistry program Cellular pharmacology and PK and PD of PRTX007 in animal models will be describedRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.